1. PharmaGPT: Domain-Specific Large Language Models for Bio-Pharmaceutical and Chemistry
- Author
-
Chen, Linqing, Wang, Weilei, Bai, Zilong, Xu, Peng, Fang, Yan, Fang, Jie, Wu, Wentao, Zhou, Lizhi, Zhang, Ruiji, Xia, Yubin, Xu, Chaobo, Hu, Ran, Xu, Licong, Cai, Qijun, Hua, Haoran, Sun, Jing, Liu, Jin, Qiu, Tian, Liu, Haowen, Hu, Meng, Li, Xiuwen, Gao, Fei, Wang, Yufu, Tie, Lin, Wang, Chaochao, Lu, Jianping, Sun, Cheng, Wang, Yixin, Yang, Shengjie, Li, Yuancheng, Jin, Lu, Zhang, Lisha, Bian, Fu, Ye, Zhongkai, Pei, Lidong, and Tu, Changyang
- Subjects
Computer Science - Computation and Language ,Computer Science - Artificial Intelligence - Abstract
Large language models (LLMs) have revolutionized Natural Language Processing (NLP) by minimizing the need for complex feature engineering. However, the application of LLMs in specialized domains like biopharmaceuticals and chemistry remains largely unexplored. These fields are characterized by intricate terminologies, specialized knowledge, and a high demand for precision areas where general purpose LLMs often fall short. In this study, we introduce PharmaGPT, a suite of domain specilized LLMs with 13 billion and 70 billion parameters, specifically trained on a comprehensive corpus tailored to the Bio-Pharmaceutical and Chemical domains. Our evaluation shows that PharmaGPT surpasses existing general models on specific-domain benchmarks such as NAPLEX, demonstrating its exceptional capability in domain-specific tasks. Remarkably, this performance is achieved with a model that has only a fraction, sometimes just one-tenth-of the parameters of general-purpose large models. This advancement establishes a new benchmark for LLMs in the bio-pharmaceutical and chemical fields, addressing the existing gap in specialized language modeling. It also suggests a promising path for enhanced research and development, paving the way for more precise and effective NLP applications in these areas.
- Published
- 2024